Mifepristone pretreatment reduces ethanol withdrawal severity in vivo

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 8, 2013, Pages 1417-1423

  Sharrett Field, Lynda ^a   Butler, Tracy R ^a   Berry, Jennifer N ^a   Reynolds, Anna R ^a   Prendergast, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcoholism; Dependence; Hormone; Hypothalamic Pituitary Adrenal Axis; Stress

Indexed keywords

ALCOHOL; ARACHIS OIL; CORTICOSTERONE; MIFEPRISTONE;

ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE SEVERITY; IN VIVO STUDY; MALE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; STEREOTYPY; TREMOR; WET DOG SHAKES;

ALCOHOLISM; DEPENDENCE; HORMONE; HYPOTHALAMIC-PITUITARY-ADRENAL AXIS; STRESS;

ALCOHOLISM; ANIMALS; BODY WEIGHT; CORTICOSTERONE; DRUG EVALUATION, PRECLINICAL; EATING; ETHANOL; HORMONE ANTAGONISTS; MALE; MIFEPRISTONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; ARACHIS HYPOGAEA; CANIS FAMILIARIS; RATTUS;

EID: 84881029873     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12093     Document Type: Article

References (47)

1. Addolorato G, Abenavoli L, Leggio L, Gasbarrini G (2005) How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology 51:59-66.
2. Adinoff B, Iranmanesh A, Veldhuis J, Fisher L (1998) Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World 22:67-72.
3. Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S (2005) Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 29:1351-1355.
4. Alele PE, Devaud LL (2007) Sex differences in steroid modulation of ethanol withdrawal in male and female rats. J Pharmacol Exp Ther 320:427-436.
5. von Bardeleben U, Heuser I, Holsboer F (1989) Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology 14:441-449.
6. Besemer F, Pereira AM, Smit JW (2011) Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. Neth J Med 69:318-323.
7. Brooks SP, Croft AP, Norman G, Shaw SG, Little HJ (2008) Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase. Neuroscience 157:376-384.
8. Chameau P, Qin Y, Spijker S, Smit AB, Joels M (2007) Glucocorticoids specifically enhance L-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J Neurophysiol 97:5-14.
9. Clarke TK, Treutlein J, Zimmermann US, Kiefer F, Skowronek MH, Rietschel M, Mann K, Schumann G (2008) HPA-axis activity in alcoholism: examples for a gene-environment interaction. Addict Biol 13:1-14.
10. Cousin MA, Lando D, Moguilewsky M (1982) Ornithine decarboxylase induction by glucocorticoids in brain and liver of adrenalectomized rats. J Neurochem 38:1296-1304.
11. Dahchour A, De Witte P (2003) Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res 27:465-470.
12. Ellis FW (1966) Effect of ethanol on plasma corticosterone levels. J Pharmacol Exp Ther 153:121-127.
13. Esel E, Sofuoglu S, Aslan SS, Kula M, Yabanoglu I, Turan MT (2001) Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol 36:572-576.
14. Fox HC, Hong KI, Siedlarz KM, Bergquist K, Anderson G, Kreek MJ, Sinha R (2009) Sex-specific dissociations in autonomic and HPA responses to stress and cues in alcohol-dependent patients with cocaine abuse. Alcohol Alcohol 44:575-585.
15. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE (1984) RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81:3879-3882.
16. Handa RJ, Burgess LH, Kerr JE, O'Keefe JA (1994) Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 28:464-476.
17. Heikinheimo O, Personen U, Huupponen R, Koulu M, Lähteenmäki P (1994) Hepatic metabolism and distribution of mifepristone and its metabolites in rats. Hum Reprod 9:40-46.
18. Heilig M, Egli M, Crabbe JC, Becker HC (2010) Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol 15:169-184.
19. Huizink AC, Ferdinand RF, Ormel J, Verhulst FC (2006) Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 101:1581-1588.
20. Jacquot C, Croft AP, Prendergast MA, Mulholland P, Shaw SG, Little HJ (2008) Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption. Alcohol Clin Exp Res 32:2107-2116.
21. Klimes-Dougan B, Hastings PD, Granger DA, Usher BA, Zahn-Waxler C (2001) Adrenocortical activity in at-risk and normally developing adolescents: individual differences in salivary cortisol basal levels, diurnal variation, and responses to social challenges. Dev Psychopathol 13:695-719.
22. Koenig HN, Olive MF (2004) The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology 29:999-1003.
23. Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-1159.
24. Lowery EG, Spanos M, Navarro M, Lyons AM, Hodge CW, Thiele TE (2010) CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 35:1241-1252.
25. Majchrowicz E (1975) Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 43:245-254.
26. Mulholland PJ, Self RL, Harris BR, Little HJ, Littleton JM, Prendergast MA (2005) Corticosterone increases damage and cytosolic calcium accumulation associated with ethanol withdrawal in rat hippocampal slice cultures. Alcohol Clin Exp Res 29:871-881.
27. Nsi-Emvo E, Chaton B, Foltzer-Jourdainne C, Gosse F, Raul F (1996) Premature expression of sucrase-isomaltase triggered by corticoid-dependent changes in polyamine metabolism. Am J Physiol 270:G54-G59.
28. O'Callaghan MJ, Croft AP, Jacquot C, Little HJ (2005) The hypothalamopituitary-adrenal axis and alcohol preference. Brain Res Bull 68:171-178.
29. Ogilvie K, Lee S, Rivier C (1997) Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res 21:467-476.
30. O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology 160:19-29.
31. Perkins HW, Linkenbach J, Dejong W (2001) Estimated blood alcohol levels reached by "binge" and "nonbinge" drinkers: a survey of young adults in Montana. Psychol Addict Behav 15:317-320.
32. Prendergast MA, Mulholland PJ (2012) Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury. Addict Biol 17:209-223.
33. Rasmussen DD, Boldt BM, Bryant CA, Mitton DR, Larsen SA, Wilkinson CW (2000) Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res 24:1836-1849.
34. Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL (2008) Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28:1641-1653.
35. Risher-Flowers D, Adinoff B, Ravitz B, Bone GH, Martin PR, Nutt D, Linnoila M (1988) Circadian rhythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse 7:37-41.
36. Rivier C, Bruhn T, Vale W (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 229:127-131.
37. Roberts AJ, Crabbe JC, Keith LD (1992) Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res 579:296-302.
38. Rosmond R, Chagnon YC, Chagnon M, Perusse L, Bouchard C, Bjorntorp P (2000) A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 49:1197-1199.
39. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology 189:175-186.
40. Self RL, Smith KJ, Butler TR, Pauly JR, Prendergast MA (2009) Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits. Neuroscience 163:868-876.
41. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM (2009) Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:1198-1208.
42. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE (2008) Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32:259-265.
43. Vendruscolo LJ, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF (2012) Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci 32:7563-7571.
44. Weiland NG, Orchinik M, Tanapat P (1997) Chronic corticosterone treatment induces parallel changes in N-methyl-D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience 78:653-662.
45. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 937:1-26.
46. Wulsin AC, Herman JP, Solomon MB (2010) Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress. Psychoneuroendocrinology 35:1100-1112.
47. Yang X, Wang S, Rice KC, Munro CA, Wand GS (2008) Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin Exp Res 32: 840-852.